Something Original is neededto harvest this miraculous Plant's forcefully persuasive, yet gentle, power.
Unless Aphria comes up with a revolutionary (proprietary formula) skin related product (topical), doubtful that its share price will advance beyond $18 -20, even at best of conditions. Without counting those in the horizon, and especially those from US, that are ready to saturate the Cannabis market, as it is there are way too many Cannabis companies versus the population that smock's and puffs the Cannabis plant. As for CBD oils, as it is, the place is already saturated (not to forger the synthetic CBD that comes out of China), except that we here in Canada cannot get it legally, the prohibition list even includes full spectrum CBD that originates from the Hemp Plant. So, we can only imagine what will happen to the sp of a Cannabis company (likely HEMP related) should it comes up with a topical creation against serious skin Health anomalies, including Leprosy afflicted skins.